'Beta blockers' diaporamas de présentation

EVIDENCE-BASED MEDICINE FOR POST MI CARE

EVIDENCE-BASED MEDICINE FOR POST MI CARE. presented by Paul St. Laurent, MSN, RN, ACNP, CCRN Acute Care Nurse Practitioner Baylor Heart and Vascular Hospital. What Do We Already Know?. TRUE OR FALSE?. Aspirin reduces the risk of myocardial infarction

2.85k views • 74 slides

In the name of God

In the name of God. Medical Care hemangioma and complications. Dr.F.Iraji. Medical Care.

994 views • 68 slides

Newer Antihypertensive Drugs

Newer Antihypertensive Drugs. BushraAbdul Hadi Philadelphia University . Hypertension: A Significant CV and Renal Disease Risk Factor. CAD. CHF LVH. Stroke. Hypertension. Renal disease. ? Morbidity ? Disability. Peripheral vascular disease.

975 views • 53 slides

Thyroid Disorders

Thyroid Disorders. G. A. (Jahan) Mozaffarian, M.D., F.A.C.P. Clinical Professor of Medicine University of Washington Jan. 25-2011 Jan. 11, 2010 5-12-2006. Thyroid Case Histories, J. S. In 1980, this 38 y/o woman was referred to our office.

1.16k views • 48 slides

The Importance of Unambiguous Medical Terminology in Patient Care and Research

588 views • 44 slides

C H A P T E R 15

C H A P T E R 15. ERGOGENIC AIDS AND SPORT. w Learn the importance of including control groups and placebos when studying the ergogenic properties of a substance. (continued). Learning Objectives.

564 views • 43 slides

Blood Pressure

Blood Pressure. Coronado Thunderbirds. Linda Macdonald, M.D. October 9, 2007. Blood Pressure. The pressure in the arterial blood vessels results from: flow of blood from the heart resistance of the arterial blood vessel walls

930 views • 37 slides

589 views • 37 slides

Drugs for CCF

Drugs for CCF. Heart failure is the progressive inability of the heart to supply adequate blood flow to vital organs. It is classically accompanied by significant fluid retention. It is a leading cause of mortality and morbidity. . Drugs for CCF.

813 views • 34 slides

TREATMENT AFTER BRAIN INJURY

519 views • 33 slides

What does the National Healthcare Agenda Mean to Us?

591 views • 23 slides

PHL 313 (lab. 5) Hypertension (HTN)

PHL 313 (lab. 5) Hypertension (HTN). Effect of some adrenergic drugs and its blockers on the blood pressure. HTN is the most common cardiovascular disease. HTN was found in 29% of American adults. 60- 80 % of men and women will develop HTN by age 80

322 views • 19 slides

Pharmacotherapy of Pain: Adjuvant Analgesics

Pharmacotherapy of Pain: Adjuvant Analgesics. Adjuvant Analgesics. Defined as drugs with other indications that may be analgesic in specific circumstances Numerous drugs in diverse classes Sequential trials are often needed. Adjuvant Analgesics. Multipurpose analgesics

1.7k views • 17 slides

Chapter 21 Muscle Blood Flow and Cardiac Output During Exercise; the Coronary Circulation and Ischemic Heart Disease

Chapter 21 Muscle Blood Flow and Cardiac Output During Exercise; the Coronary Circulation and Ischemic Heart Disease. Flow rate in muscle. 4 ml/min/100 g to 80-100 ml/min/100 g Intermittent as a result of contraction of muscle Exercise opens capillaries

620 views • 17 slides

QUALITY USE OF CARDIOVASCULAR MEDICATION

325 views • 14 slides

Pharmacological management of post stroke patients

Pharmacological management of post stroke patients. By Khalid Khan Pharmacist HASU. Plan. Stroke- definition, classification-covered elsewhere Drug history and medicines reconciliation Secondary prevention Antiplatelets Lipid regulating drugs- statins Antihypertensives

561 views • 13 slides

Secondary prevention of myocardial infarction (MI) Drug therapy

Secondary prevention of myocardial infarction (MI) Drug therapy. Prophylaxis for patients who have experienced an MI NICE Clinical Guideline 43. May 2007. ACE-Is should be offered to all patients early after presentation with acute MI

822 views • 9 slides

Managing Patients with Hypertension and Heart Failure

216 views • 7 slides

The Scottish Patient Safety Programme

The Scottish Patient Safety Programme. Title of the session & name of faculty. National Networking Event Peri Operative Workstream. IHI Model for Improvement. AIM : What Are We Trying To Accomplish . MEASURE : How Will We Know The Change Is An Improvement?

226 views • 3 slides

SURGICAL CARE IMPROVEMENT PROJECT

SURGICAL CARE IMPROVEMENT PROJECT. The focus of this measure is to provide appropriate and timely antibiotic prophylaxis, cardiac care, and venous thromboembolism prophylaxis. Infection prevention is crucial!. Document temperature management/use of forced air warming.

341 views • 1 slides